SCHEMBL2552826

SCHEMBL2552826

CCCCc1cc(CC)ccn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 3/20 0.52
NOS3 P29474 2/20 0.52
NOS1 P29475 2/20 0.52
LMNA P02545 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRA1 P14867 1/20 0.41
IDO1 P14902 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRE P78334 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2550616 0.94 NOS3 (0.50) NOS2NOS3NOS1LMNAKDM4E
SCHEMBL31280277 0.94 NOS3 (0.50) NOS2NOS3NOS1LMNAKDM4E
SCHEMBL30019258 0.92 KCNH2 (0.48) NOS2NOS3NOS1LMNAKDM4E
Tetradecane SCHEMBL27660314 0.92 KCNH2 (0.48) NOS2NOS3NOS1LMNAKDM4E
SCHEMBL27630660 0.92 KCNH2 (0.48) NOS2NOS3NOS1LMNAKDM4E
SCHEMBL2555626 0.92 KCNH2 (0.48) NOS2NOS3NOS1LMNAKDM4E
SCHEMBL13337725 0.92 NOS3 (0.55) NOS2NOS3NOS1LMNAKDM4E
Bromide SCHEMBL9300889 0.91 KCNH2 (0.47) NOS2NOS3NOS1LMNAKDM4E
Hydrochloric Acid SCHEMBL28148327 0.91 KCNH2 (0.47) NOS2NOS3NOS1LMNAKDM4E
SCHEMBL6560564 0.90 KDM4E (0.44) NOS2NOS3NOS1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8652452-B2 2,4-disubstituted pyridines as perfuming ingredients FIRMENICH SA (CH) 2014-02-18 US disclosed
EP-2552395-B1 2,4-disubstituted pyridines as perfuming ingredients FIRMENICH & CIE (CH) 2013-11-13 EP disclosed
EP-2552395-A1 2,4-DISUBSTITUTED PYRIDINES AS PERFUMING INGREDIENTS Firmenich S.A. (CH) 2013-02-06 EP disclosed
US-20130004447-A1 2,4-DISUBSTITUTED PYRIDINES AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2013-01-03 US disclosed
WO-2011121469-A1 2,4-DISUBSTITUTED PYRIDINES AS PERFUMING INGREDIENTS FIRMENICH SA (CH) 2011-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130004447-A1 2,4-DISUBSTITUTED PYRIDINES AS PERFUMING INGREDIENTS P2RX5, P2RX4, C5 NOS2 927/4885NOS3 819/4885NOS1 1214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.